Catalyst Pharmaceuticals (CPRX) Net Cash Flow Growth (1y) (2011 - 2026)
Catalyst Pharmaceuticals (CPRX) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 301.06% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | -26.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.01% |
| Dec 31, 2025 | -74.37% |
| Sep 30, 2025 | -44.34% |
| Jun 30, 2025 | 10.51% |
| Mar 31, 2025 | -63.48% |
| Dec 31, 2024 | 351.38% |
| Sep 30, 2024 | 215.26% |
| Jun 30, 2024 | 113.76% |
| Mar 31, 2024 | 215.07% |
| Dec 31, 2023 | -60.63% |
| Sep 30, 2023 | -228.04% |
| Jun 30, 2023 | 31.64% |
| Mar 31, 2023 | -2,267.58% |
| Dec 31, 2022 | 154.86% |
| Sep 30, 2022 | 131.07% |
| Jun 30, 2022 | 191.19% |
| Mar 31, 2022 | 338.12% |
| Dec 31, 2021 | 26.49% |
| Sep 30, 2021 | 851.36% |
| Jun 30, 2021 | -40.10% |